Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm

WHO SAGE Working Group on COVID-19 Vaccines; (2021) Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm. Technical Report. World Health Organisation, Geneva. https://apps.who.int/iris/handle/10665/341251

Permanent Identifier

Use this permanent URL when citing or linking to this resource.

https://apps.who.int/iris/handle/10665/341251

Abstract

Item Type Monograph
Elements ID 165215
Official URL https://apps.who.int/iris/handle/10665/341251

Share

Download

Restricted to: Repository staff only

Filename: WHO-2019-nCoV-vaccines-SAGE-recommendation-BIBP-2021.1-eng.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Google Scholar